Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Frank Kuwamura

Orthopaedic Surgery of the Spine Shavano Park, TX Medical Doctor

NPI 1184671398 CMS profile 7982

3503 Paesanos Pkwy Ste 201, Shavano Park, TX 78231

Open in the dashboard

General payments

$191,358

180 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Frank Kuwamura of Shavano Park, TX is reported in the CMS Open Payments database as having received $191,358 across 180 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 83rd percentile of Orthopaedic Surgery of the Spine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $4,238 34
2024 General $4,467 30
2023 General $8,932 34
2022 General $17,385 16
2021 General $53,309 19
2020 General $62,550 18
2019 General $40,477 29

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Frank Kuwamura
  • Orthopaedic Surgery of the Spine median
  • Middle half of Orthopaedic Surgery of the Spine
  • National median

In program year 2025, general payments to Frank Kuwamura were reported at $4,238. Among 1,704 Orthopaedic Surgery of the Spine profiles paid that year, the median was $2,061 and the middle half received between $347 and $14,651.

Show as a table
Year Frank Kuwamura Orthopaedic Surgery of the Spine median Middle half National median
2019 $40,477 $2,106 $337–$18,608 $163
2020 $62,550 $1,213 $156–$15,082 $114
2021 $53,309 $1,834 $271–$15,617 $132
2022 $17,385 $2,015 $320–$17,036 $149
2023 $8,932 $1,925 $336–$14,599 $160
2024 $4,467 $2,110 $341–$12,483 $164
2025 $4,238 $2,061 $347–$14,651 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Fuse Medical, Inc. $125,455 14 payments
  2. Alphatec Spine, Inc $48,780 22 payments
  3. Nexus Spine, LLC $7,779 12 payments
  4. Spineart USA Inc $2,855 5 payments
  5. CoreLink, LLC $861 4 payments
  6. SI-BONE, Inc. $752 18 payments
  7. Providence Medical Technology, Inc. $667 7 payments
  8. Abbott Laboratories $625 12 payments
  9. CPM Medical Consultants, LLC $512 8 payments
  10. Intrinsic Therapeutics $404 10 payments
  11. Other $2,669 68 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $132,294 18 payments
  2. Royalty or License $48,780 22 payments
  3. Food and Beverage $6,672 131 payments
  4. Travel and Lodging $3,275 7 payments
  5. Gift $337 2 payments
Products named General payments · program years 2019–2025
  1. BATALLION LATERAL $26,180 4 payments
  2. Battalion LLIF $21,713 17 payments
  3. PressOn $7,779 12 payments
  4. Other - Miscellaneous $887 1 payment
  5. IFUSE IMPLANT $657 14 payments
  6. BARRICAID ACD (ANNULAR CLOSURE DEVICE) Annular Closure Device $404 10 payments
  7. BARRICAID ACD (ANNULAR CLOSURE DEVICE) Annular Closure Device $404 10 payments
  8. PROCLAIM $286 2 payments
  9. MAXFUSE-C $276 3 payments
  10. INTELLIS ADAPTIVESTIM $232 6 payments
  11. Other $2,176 74 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

13

Median for Orthopedic Surgery: 203

Drug cost

$132

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 13 $132

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 41 billing codes

Paid by Medicare

$108,314

Medicare's payments for the services billed

Medicare patients

132

Average age 73

Services billed

450

74 women, 58 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 34%
Ischemic heart disease 30%
Depression 30%
Chronic kidney disease 20%
Osteoporosis 20%
Atrial fibrillation 18%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

180 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery of the Spine in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record